이법표

이법표, listed as chief executive, appears in our data through filings on 바스칸바이오제약 shares, published by DART (FSS). Over a trading history stretching from 20 July 2022 to 24 March 2026, the count stands at 8 filings.

Sales make up the whole of the open-market record (8 sales). No amount is published for 8 filings, which the totals therefore leave out. Since January 2026: no purchases and 1 sale on the market.

The latest filing, published on 30 March 2026, reports an open-market sale in 바스칸바이오제약. Typically, a trade is published a median of 1 day after it takes place. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from DART (FSS). Past trades are no guide to future returns.